Daniel Faga

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Faga:

Company Role Class Num Shares Value Price $ Report Date Ownership
ANAPTYSBIO, INC President, CEO, Director Common Stock 436,466 $6,677,930 $15.3 06 Jan 2025 Direct
ANAPTYSBIO, INC President, CEO, Director Restricted Stock Unit 107,350 $1,390,247 $12.95 07 Jan 2025 Direct
ANAPTYSBIO, INC President, CEO, Director Restricted Stock Unit 53,550 $1,167,926 $21.81 06 Jan 2024 Direct
ANAPTYSBIO, INC President, CEO, Director Stock Option (right to buy) 305,500 07 Jan 2025 Direct

Insider Reports Filed by Daniel Faga

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANAB ANAPTYSBIO, INC 03 Jan 2025 8 -$288,002 4 President, CEO, Director 07 Jan 2025, 17:27
ANAB ANAPTYSBIO, INC 22 Jul 2024 1 $0 4 CEO, Director 24 Jul 2024, 16:15
ANAB ANAPTYSBIO, INC 22 Mar 2024 3 -$10,894,177 4 CEO, Director 26 Mar 2024, 20:10
ANAB ANAPTYSBIO, INC 06 Jan 2024 3 -$149,747 4 CEO, Director 09 Jan 2024, 19:05
ANAB ANAPTYSBIO, INC 03 Jan 2024 2 $0 4 CEO, Director 05 Jan 2024, 16:52
ANAB ANAPTYSBIO, INC 06 Jan 2023 2 $0 4 Interim CEO, Director 10 Jan 2023, 18:04
ANAB ANAPTYSBIO, INC 21 Mar 2022 1 $0 4 Interim CEO, Director 23 Mar 2022, 16:48
ANAB ANAPTYSBIO, INC 10 Feb 2022 1 $0 4 Director 14 Feb 2022, 15:43
ANAB ANAPTYSBIO, INC 26 Nov 2021 2 $0 4 Director 30 Nov 2021, 16:26
ANAB ANAPTYSBIO, INC 26 Nov 2021 0 $0 3 Director 30 Nov 2021, 16:23